by Oncospherix | Nov 17, 2021 | General
OncoSpherix’s CEO, Margaret K Offermann, MD, PhD, is a keynote speaker at the 3rd Meridian Drug Discovery Virtual Conference on November 19, 2021. She will be presenting an update on the science of OncoSpherix, with special focus on the chemistry of their clinical...
by Oncospherix | Nov 11, 2021 | General
OncoSpherix’s CEO, Margaret “Kenny” Offermann, will be a panelist in Biolocity’s Bench to Market series as part of a panel presenting “Tales from the Trenches” on Wednesday, Nov 17, 2021 at 11:30 AM Eastern Time. Attendance is free following registration at:...
by Oncospherix | Nov 11, 2021 | General
OncoSpherix will be participating at Life Science Nations’ Digital RESI (Redefining Early Stage Investments) on Nov 16-18, 2021 and has been selected for participation in the Innovator’s Pitch Challenge. A brief video, slide deck and executive summary can be found at...
by Oncospherix | Oct 22, 2021 | General
OncoSpherix is pleased to announce that it was selected for the investor pitch portion of the annual AdvanSE conference that is being held in Charleston, SC, October 27-29, 2021. The AdvanSE conference is an annual event for Southeast Life Sciences (SELS), an...
by Oncospherix | Oct 20, 2021 | General
OncoSpherix will launch the Company Showcase at this year’s Georgia Bio Innovation Summit with a presentation entitled “Advancing Dual First-in-Class HIF-Inhibitors for Advanced Solid Cancers”. The recorded presentation will be available to registered attendees...
by Kendyle Woodard | Sep 22, 2021 | General
OncoSpherix, Inc. is pleased to announce that Kendyle Woodard, MBA, is serving as Chief Operating Officer for the company. Ms. Woodard is a business operations executive with 20+ years of experience in management, marketing and business development supporting...
